Stip, Marjolein C; Evers, Mitchell; Nederend, Maaike; Chan, Chilam; Reiding, Karli R; Damen, Mirjam J; Heck, Albert J R; Koustoulidou, Sofia; Ramakers, Ruud; Krijger, Gerard C; de Roos, Remmert; Souteyrand, Edouard; Cornel, Annelisa M; Dierselhuis, Miranda P; Jansen, Marco; de Boer, Mark; Valerius, Thomas; van Tetering, Geert; Leusen, Jeanette H W; Meyer-Wentrup, Friederike
(BioMed Central, 2023-07-21)
BACKGROUND: Immunotherapy targeting GD2 is very effective against high-risk neuroblastoma, though administration of anti-GD2 antibodies induces severe and dose-limiting neuropathic pain by binding GD2-expressing sensory ...